50222-346 : Adbry 150 mg/ml Subcutaneous Injection, Solution
NDC: | 50222-346 |
Labeler: | Leo Pharma Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Adbry |
Dosage Form: | Subcutaneous Injection, Solution |
Application #: | BLA761180 |
Rev. Date: |
NDC Package Codes:
- 50222-346-02: 2 SYRINGE, GLASS IN 1 CARTON (50222‑346‑02) > 1 ML IN 1 SYRINGE, GLASS
- 50222-346-04: 2 CARTON IN 1 CARTON (50222‑346‑04) > 2 SYRINGE, GLASS IN 1 CARTON (50222‑346‑22) > 1 ML IN 1 SYRINGE, GLASS
- 50222-346-92: 2 SYRINGE, GLASS IN 1 CARTON (50222‑346‑92) > 1 ML IN 1 SYRINGE, GLASS
Active Ingredients:
- Tralokinumab
Dosage Strength:
- 150 mg/mL
Pharmaceutical Classes:
- Interleukin-13 Antagonist [EPC]
- Interleukin-13 Antagonists [MoA]
Related Products:
Based on records with the same trade name.- 50222-350 Adbry 300 mg/2ml Subcutaneous Injection, Solution by Leo Pharma Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 50222-342Next: 50222-350 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.